ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 82 filers reported holding ALLOVIR INC in Q4 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,481,732 | -36.5% | 1,154,294 | +0.5% | 0.02% | -33.3% |
| Q2 2023 | $3,906,804 | -13.3% | 1,149,060 | +0.5% | 0.02% | -20.0% |
| Q1 2023 | $4,506,884 | -23.2% | 1,143,879 | +0.0% | 0.03% | -26.8% |
| Q4 2022 | $5,866,565 | -35.0% | 1,143,580 | -0.0% | 0.04% | -37.9% |
| Q3 2022 | $9,023,000 | +102.3% | 1,143,634 | +0.0% | 0.07% | +120.0% |
| Q2 2022 | $4,460,000 | -42.2% | 1,143,425 | -0.0% | 0.03% | -28.6% |
| Q1 2022 | $7,719,000 | -47.9% | 1,143,532 | -0.1% | 0.04% | -43.2% |
| Q4 2021 | $14,810,000 | -48.4% | 1,144,562 | -0.0% | 0.07% | -51.6% |
| Q3 2021 | $28,695,000 | +44.6% | 1,145,032 | +13.9% | 0.15% | +128.4% |
| Q2 2021 | $19,847,000 | -15.7% | 1,005,415 | -0.1% | 0.07% | -19.3% |
| Q1 2021 | $23,544,000 | -32.7% | 1,006,142 | +10.5% | 0.08% | -36.2% |
| Q4 2020 | $34,997,000 | +11763.4% | 910,419 | +8394.3% | 0.13% | +12900.0% |
| Q3 2020 | $295,000 | – | 10,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $63,893,000 | 1.55% |
| Redmile Group, LLC | 2,333,390 | $64,168,000 | 1.18% |
| Woodline Partners LP | 1,191,014 | $32,753,000 | 1.07% |
| EcoR1 Capital, LLC | 447,012 | $12,293,000 | 0.88% |
| Samsara BioCapital, LLC | 91,057 | $2,504,000 | 0.70% |
| SECTORAL ASSET MANAGEMENT INC | 277,795 | $7,639,000 | 0.66% |
| CNA FINANCIAL CORP | 10,745 | $295,000 | 0.11% |
| Marshall Wace North America L.P. | 580,880 | $15,974,000 | 0.10% |
| MIRABELLA FINANCIAL SERVICES LLP | 16,791 | $462,000 | 0.06% |
| Alkeon Capital Management | 1,097,000 | $30,167,000 | 0.06% |